Howard W Robin - Net Worth and Insider Trading

Howard W Robin Net Worth

The estimated net worth of Howard W Robin is at least $4 Million dollars as of 2026-08-09. Howard W Robin is the President & CEO of Nektar Therapeutics and owns about 55,073 shares of Nektar Therapeutics (NKTR) stock worth over $4 Million. Details can be seen in Howard W Robin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Howard W Robin has not made any transactions after 2026-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Howard W Robin

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Howard W Robin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Howard W Robin owns 1 companies in total, including Nektar Therapeutics (NKTR) .

Click here to see the complete history of Howard W Robin’s form 4 insider trades.

Insider Ownership Summary of Howard W Robin

Ticker Company Transaction Date Type of Owner
NKTR Nektar Therapeutics 2026-06-17 director & President & CEO

Howard W Robin Latest Holdings Summary

Howard W Robin currently owns a total of 1 stock. Howard W Robin owns 55,073 shares of Nektar Therapeutics (NKTR) as of June 17, 2026, with a value of $4 Million.

Latest Holdings of Howard W Robin

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NKTR Nektar Therapeutics 2026-06-17 55,073 76.48 4,211,983

Holding Weightings of Howard W Robin


Howard W Robin Form 4 Trading Tracker

According to the SEC Form 4 filings, Howard W Robin has made a total of 25 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 25 sells. The most-recent trade in Nektar Therapeutics is the sale of 20,000 shares on June 17, 2026, which brought Howard W Robin around $1 Million.

Insider Trading History of Howard W Robin

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Howard W Robin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Howard W Robin owns.
View NKTR Analysis

Howard W Robin Ownership Network

Ownership Network List of Howard W Robin

No Data

Ownership Network Relation of Howard W Robin

Insider Network Chart


Howard W Robin Owned Company Details

What does Nektar Therapeutics do?

Who are the key executives at Nektar Therapeutics?

Howard W Robin is the director & President & CEO of Nektar Therapeutics. Other key executives at Nektar Therapeutics include Chief R&D Officer Jonathan Zalevsky , Interim CFO Linda M Rubinstein , and Chief Legal Officer Mark Andrew Wilson .

Nektar Therapeutics (NKTR) Insider Trades Summary

Over the past 18 months, Howard W Robin made 10 insider transaction in Nektar Therapeutics (NKTR) with a net sale of 91,627. Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 40,565 shares made by Jonathan Zalevsky , a net sale of 22,342 shares made by Mark Andrew Wilson ,

In summary, during the past 3 months, insiders sold 31,862 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 31,862 shares. During the past 18 months, 71,439 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 71,439 shares.

Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nektar Therapeutics Insider Transactions

No Available Data

Howard W Robin Mailing Address

Above is the net worth, insider trading, and ownership report for Howard W Robin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Howard W Robin's mailing address is: San Francisco Ca 94158.